| 名稱 | PDL1/MHCII APC Cell |
| 型號(hào) | CBP74147 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | PDL1/MHCII APC Cell 凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 特應(yīng)性皮炎(AD)賽道新治療——OX40靶點(diǎn)
- DPCR檢測(cè)試劑盒開(kāi)發(fā)性能驗(yàn)證
- 子宮內(nèi)膜癌精準(zhǔn)分子分型標(biāo)準(zhǔn)品，助力POLE基因檢測(cè)
- 淺談NTRK fusion
- ADCC/ADCP細(xì)胞篩選模型
- AKT E17K突變抑制劑細(xì)胞篩選模型介紹
- 一起認(rèn)識(shí)下腫瘤細(xì)胞的遷移性
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn)，國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- FGFR2融合靶向藥物細(xì)胞篩選模型
- 腫瘤細(xì)胞內(nèi)的膠原蛋白有哪些作用？
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74147PDL1/MHCII APC Cell
- 詳細(xì)內(nèi)容
| CBP74147 | |
| I. Background | |
| The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. diabetes. | |
| II. Introduction | |
| Expressed gene: | PD1、LAG3 |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin+10ug/ml blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
| |
Figure 1. Dose Response of Blocking Antibodies in PD-1/LAG3 Dual Effector Reporter Cells (C15) With PD-L1/MHCII APC Cells. | |
會(huì)員_a.png)